Status:
COMPLETED
Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Lovisenberg Diakonale Hospital
Collaborating Sponsors:
University of Oslo
Norwegian Foundation for Health and Rehabilitation
Conditions:
COPD
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
There is a demand for explorative and comparative studies on various non-pharmaceutical efforts in treating and helping chronic obstructive pulmonary disease patients. This study has been developed in...
Eligibility Criteria
Inclusion
- Dyspnoea symptoms in daily life
- Spirometry values showing a COPD moderate stage II (FEV1/FVC\<70%, FEV1\<80%) and severity grade at a severe stage III (FEV1/FVC\<70%, FEV1\<50% and FEV1 = 30% of a predicted)
- Be able to read, write and speak Norwegian
- Be at a stable phase of the disease
Exclusion
- Changes in pulmonary medication during the last 4 weeks
- Diagnosis of cancer
- Presently attending a pulmonary rehabilitation course or other similar COPD education courses (due to the fact that these courses often have instructions on breathing control), or having attended similar courses during the last six months
- Ongoing exacerbation
- Attending other competitive studies
- Diagnosis of neuromuscular disease
- Diagnosis of dementia
- Attending help from a pulmonary physiotherapist
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01512043
Start Date
July 1 2011
End Date
September 1 2013
Last Update
May 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lovisenberg Diakonale Hospital
Oslo, Norway, 0440